FIELD: medicine.
SUBSTANCE: invention represents a method for predicting a risk of isolated hysteromyoma involving sampling and studying peripheral venous blood, differing by the fact that DNA is recovered from the peripheral venous blood; genetic polymorphisms of interleukin genes are typed, and combinations of polymorphisms of interleukin-1 (-889 TT IL-1) and interleukin-5 (-703 C IL-5) genes are analysed; a high risk of isolated hysteromyoma is predicted, if observing a combination of -889 TT IL-1 allele and -703 C IL-5 allele in Russian females, native of the Central Black Earth Region.
EFFECT: invention provides obtaining criteria of the risk of isolated hysteromyoma as shown by the combination of the molecular-genetic markers 889 TT IL-1A and -703 C IL-5.
1 ex, 1 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF UTERINE FIBROID | 2017 |
|
RU2650990C1 |
| METHOD FOR PREDICTION OF RISK OF HYPERPLASTIC PROCESSES OF ENDOMETRIUM | 2014 |
|
RU2557977C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF MYOMATOUS NODES OF LARGE SIZES IN PATIENTS WITH MYOMA | 2016 |
|
RU2616246C1 |
| METHOD OF PREDICTING DEVELOPMENT OF RISK OF COMBINED PROLIFERATIVE REPRODUCTIVE SYSTEM DISEASES IN WOMEN | 2014 |
|
RU2557954C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING COMBINATION OF UTERINE FIBROIDS AND ADENOMYOSIS USING GENETIC DATA | 2018 |
|
RU2677866C1 |
| METHOD FOR FORECASTING RISK OF DEVELOPMENT OF COMBINATION OF UTERINE FIBROID AND ENDOMETRIAL HYPERPLASTIC PROCESSES | 2018 |
|
RU2678970C1 |
| METHOD FOR PREDICTING RISK OF ENDOMETRIAL HYPERPLASTIC PROCESSES BASED ON GENETIC DATA | 2017 |
|
RU2650988C1 |
| METHOD FOR PREDICTION OF RISK OF ENDOMETRIOSIS | 2014 |
|
RU2558854C1 |
| METHOD FOR PREDICTION OF RISK OF RECURRENCE OF SYMPTOMATIC UTERINE MYOMA AFTER SELECTIVE EMBOLIZATION OF UTERINE ARTERIES | 2021 |
|
RU2766809C1 |
| METHOD FOR PREDICTION OF RISK OF GENITAL ENDOMETRIOSIS | 2017 |
|
RU2650994C1 |
